Sarah Cannon Outcomes Registry

Oncology Clinical Trial

Official title:

Sarah Cannon Outcomes Registry

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02356822
• Other study ID #: SCRI HEOR_01
• Status: Withdrawn
• Start date: December 2014
• Est. completion date: December 2024

Study information

• Verified date: June 2019
• Source: SCRI Development Innovations, LLC
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.

Description:

Q

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2024
• Est. primary completion date: December 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 or older

• Patients that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship.

• Patient must have the ability to understand the nature of the trial and give written informed consent

Exclusion Criteria:

• There are no exclusion criteria for this Outcomes Registry

Related Conditions & MeSH terms

• Neoplasms
• Oncology

Intervention

Other:
• Patient registry
Oncology data registry

Locations

Country	Name	City	State
United States	SCRI	Nashville	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
SCRI Development Innovations, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	safety and effectiveness		10 yrs
Primary	quality improvement		10 yrs
Primary	Treatment patterns and utilization		5 yrs
Secondary	Humanistic and economic outcomes		10 yrs